Pfizer has been cleared in the UK for use of their Covid-19 Vaccine. This comes from an Emergency Use Authorization and it clears the way for Pfizer to begin deploying the vaccine. Health Secretary Matt Hancock said, “This is going to be one of the biggest civilian projects in history” as 50 hospitals in the UK are preparing to administer 800,000 doses of the vaccine beginning next week. Hancock continued, “We can see the way out, and we can see that by the spring we are going to be through this.”
The U.K. regulator, the Medicines and Healthcare Products Regulatory Agency, declared the vaccine “met its strict standards of safety, quality and effectiveness.”. As of right now the UK has enough of the two-dose vaccine planned to inoculate 20 million people. Pfizer says they can produce 1.3 billion doses next year, however that supply is already committed to other locations around the globe.
This news comes as other vaccine companies have faced delays. Here are some of the companies that are still in the testing phase for their vaccines.
“Moderna’s mRNA-1273 uses messenger RNA to prompt the body to make a key protein from the virus, creating an immune response.”
Moderna’s vaccine is in Phase 3 of testing
The University of Oxford, AstraZeneca Plc
“The vaccine is made from a harmless virus that’s been altered to produce the surface spike protein from SARS-CoV-2.”
The Astra Vaccine is in Phase 3 of testing
Johnson & Johnson
“J&J is working on an unnamed adenovirus-based vaccine as well as two backups.”
Johnson & Johnson’s vaccine is in Phase 3 of testing.
“Novavax’s vaccine consists of synthetic spike proteins grown in armyworm moth cells.”
The Novavax accine is in Phase 3 of testing